Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: An ex vivo study
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1), 395-401
- https://doi.org/10.1016/0002-8703(91)90878-l
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic studyAmerican Heart Journal, 1991
- New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertensionAmerican Heart Journal, 1989
- Efficacy and safety of doxazosin in hypertension therapyThe American Journal of Cardiology, 1987
- Status of risk factors and their consideration in antihypertensive therapyThe American Journal of Cardiology, 1987
- Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.British Journal of Clinical Pharmacology, 1986
- Platelet-inhibitor therapy in cardiovascular diseasePostgraduate Medicine, 1985
- Risk factor analysisProgress in Cardiovascular Diseases, 1984
- Platelets and Ischemic Heart DiseaseNew England Journal of Medicine, 1980
- Role of blood platelets in coronary artery diseaseThe American Journal of Cardiology, 1979
- Epidemiologic Assessment of the Role of Blood Pressure in StrokeJAMA, 1970